Analyst consensus rating
ADC Therapeutics Analyst Rating: none
Direct answer
ADC Therapeutics's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $3.33.
Forecast evidence checked November 3, 2026.
Get free ADC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.54
- Average price target
- $3.33
- High price target
- $5.00
- Low price target
- $2.00
- Low target gap
- +29.9%
- Target upside
- +116.4%
- High target gap
- +224.7%
- Target range width
- 194.8%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- November 3, 2026
- Valid through
- November 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for ADC Therapeutics?
ADC Therapeutics has a verified none consensus. The same dataset has an average price target of $3.33.
How far are ADC Therapeutics's low and high targets from the recorded price?
The low target implies +29.9%, while the high target implies +224.7%.
How many analysts are included in ADC Therapeutics's consensus?
The verified consensus includes 3 analysts.
How is ADC Therapeutics's target upside or downside calculated?
The average target of $3.33 is divided by the recorded price of $1.54, then one is subtracted to produce +116.4%. This does not guarantee a future return.
When was ADC Therapeutics's analyst forecast verified?
The data was verified on 2026-11-03. The dataset is valid through 2026-11-10.